Clinical Practice Pearls: Managing Patients with Major Depressive Disorder Showing an Inadequate Response to First-Line Therapies
Podcast #3: Recurrent MDD treatment once SSRIs are no longer effective
Post-Test/Evaluation
Exit Survey
Questions marked with a
*
are required
20%
Contact Information
First Name
Last Name
Email Address
Credentials/Degree (MD, DO, RN, etc.)
Date of Participation
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2018
2019
2020
2021
2022
2023
2024
2025
A 55-year-old man is diagnosed with severe depression. His PHQ-9 score is 21 and GAD-7 score is 8. Sertraline is initiated at 50 mg/d, increasing to 100 mg/d after 1 week. At his follow up 4 weeks later, he shows improvement in mood and interest, but sleep and concentration remain disrupted. PHQ-9 total score is 16. Sertraline is increased to 150 mg/d, and then to 200 mg/d. Anxiety is improved, with a PHQ-9 score of 11, driven by residual symptoms of insomnia, low energy, and problems with concentration/cognition. Interest, mood, and appetite are near normal. What would be a reasonable next step?
Switch to an SNRI
Switch to bupropion
Switch to vortioxetine
Switch to a different SSRI
Patient preferences should be considered when recommending hospitalization to treat moderate-to-severe alcohol use disorder based on an AUDIT score of 16.
True
False
Start
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close